LONDON -- Before investing in a company, it's important to gauge what the rest of the market thinks. This will help you understand what would be needed for the share price to move significantly.
City research analysts are paid to give their verdicts on listed companies. I've scanned the FTSE 100 to find the companies that have the highest proportion of positive recommendations issued against them by the analysts. Here are three more of the most popular shares on the market.
Shire is the smallest of the FTSE 100's three pharmaceuticals companies. It has thrived from the sale of its attention deficit disorder treatments. A boom in diagnosis of this condition in developed countries has led sales to nearly double in the last five years. In that time, earnings per share has increased by an average of 30.1% per annum.
The company is expected to increase its dividend for 2012 by 30%, and that's to be followed by a similar increase for 2013. The shares trade on a 2013 price-to-earnings ratio of 14.3 times expectations. That's the lowest rating that the shares have been on since the financial crisis.
Rexam is a packaging company, specializing in cans for the soft-drinks industry. This is a business with significant economies of scale and predictable sales demand. These factors and Rexam's modest valuation are the likely cause of the share's popularity. The shares are up 7.9% so far in 2013.
Rexam announced final results earlier this week. The company reported EPS up 5% and dividends up 6%. Brokers are forecasting that Rexam will make EPS of 42.3 pence for 2013, rising to 45.4 pence for 2014. The dividend is expected to hit 20.5 pence in 2014, putting the shares on a yield for the year of 4.1%.
Like those of many fund managers, Schroders' profits are geared to the health of the financial markets.
Schroders is forecast to report EPS of 128.5 pence for 2012, rising to 141.2 pence this year. This puts the shares on a slight P/E discount to the rest of the companies in the FTSE 100. Schroders shares trade on a forecast yield for 2012 of 2.9%, rising to 3.2% for 2013. Future movements in the markets will have a big effect on the company's profits. If you expect the current bull market to continue, Schroders could be a very good bet indeed.
Owning shares in a company whose profits are geared to the success of the market could make you big gains when shares rise. To learn more about how you can use the power of the stock market to boost your wealth, get the free Motley Fool report "10 Steps To Making A Million In The Market." This report is totally free and could transform the way you invest forever. Simply click here to get this report delivered to your inbox today.
David does not own shares in any of the above companies. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.
More from The Motley Fool
Should I Buy These 5 Shares?
Harvey Jones takes a second look at Rolls-Royce Holdings, ARM Holdings, Wolseley, Schroders, and Standard Chartered.
Are These FTSE 100 Shares a Buy?
Royston Wild studies Hargreaves Lansdown, Schroders, Resolution, Capita, and Standard Life.
Should I Invest in These 5 FTSE 100 Shares?
Can BHP Billiton, Severn Trent, Whitbread, Schroders, and Aggreko deliver market-beating total returns?